Phase I study examining PI 3 kinase inhibitor for various tumours
Dr Pamela Munster – University of California, San Francisco, USA
Phase I study examining PI 3 kinase inhibitor for various tumours ( Dr Pamela Munster – University of California, San Francisco, USA )
4 Oct 2012
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-p...
Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
30 Sep 2012
Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib
Dr Tony Mok - Chinese University of Hong Kong
Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib ( Dr Tony Mok - Chinese University of Hong Kong )
29 Sep 2012
Sorafenib does not extend overall survival as third or fourth line therapy in lu...
Dr Luis Paz-Ares - Virgen del Rocio University Hospital in Seville, Spain
Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer – Phase III MISSION trial ( Dr Luis Paz-Ares - Virgen del Rocio University Hospital in Seville, Spain )
29 Sep 2012
Tobacco control and prevention through social media
Joan Bottorff – University of British Columbia, Kelowna, Canada
Tobacco control and prevention through social media ( Joan Bottorff – University of British Columbia, Kelowna, Canada )
21 Sep 2012
Cancer prevention and epidemiology in Russia
Dr David Zardize – Russian National Cancer Research Centre, Moscow, Russia
Cancer prevention and epidemiology in Russia ( Dr David Zardize – Russian National Cancer Research Centre, Moscow, Russia )
20 Jul 2012
Importance of cancer prevention
Prof Murat Tuncer - Hacettepe University, Ankara, Turkey
Importance of cancer prevention ( Prof Murat Tuncer - Hacettepe University, Ankara, Turkey )
20 Jul 2012
Epigenetics of cancer and changes in DNA modification in tumours
Prof Manel Esteller – University of Barcelona, Catalonia, Spain
Epigenetics of cancer and changes in DNA modification in tumours  ( Prof Manel Esteller – University of Barcelona, Catalonia, Spain   )
16 Jul 2012
Drug development in small cell and non-small cell lung cancer
Dr Leora Horn - Vanderbilt-Ingram Cancer Center, Nashville, USA
Drug development in small cell and non-small cell lung cancer ( Dr Leora Horn - Vanderbilt-Ingram Cancer Center, Nashville, USA  )
18 Jun 2012
Afatinib delays progression of advanced lung adenocarcinomas
Dr James Yang - National Taiwan University Hospital, Taipei
Afatinib delays progression of advanced lung adenocarcinomas ( Dr James Yang - National Taiwan University Hospital, Taipei )
4 Jun 2012
Routine molecular testing of non-small cell lung cancers in community settings
Dr Thomas Zander - University Hospital Cologne, Germany
Routine molecular testing of non-small cell lung cancers in community settings ( Dr Thomas Zander - University Hospital Cologne, Germany )
4 Jun 2012
Increased progression-free survival in advanced lung cancer with afatinib
Dr James Yang - National Taiwan University Hospital Taipei, Taiwan
Increased progression-free survival in advanced lung cancer with afatinib  ( Dr James Yang - National Taiwan University Hospital Taipei, Taiwan )
3 Jun 2012